PR Newswire: Zelira Therapeutics Expands HOPE™ Distribution in the US Through Licensing Agreement with Alternative Solutions in Washington DC
Previous
Previous
Green Market Report: Zelira Therapeutics Announces Licensing Agreement with Alternative Solutions to Expand HOPE™ Distribution to Include Washington DC
Next
Next